Copyright
©The Author(s) 2023.
World J Clin Oncol. Aug 24, 2023; 14(8): 297-310
Published online Aug 24, 2023. doi: 10.5306/wjco.v14.i8.297
Published online Aug 24, 2023. doi: 10.5306/wjco.v14.i8.297
Figure 4 Stromal and immune scores in relation to six-transmembrane epithelial antigen of the prostate 4 in gastric cancer.
A: Tumor purity; B: Stromal score; C: Immune score; D: ESTIMATE score; E: Tumor purity was higher in the six-transmembrane epithelial antigen of the prostate 4 (STEAP4) low expression group; F-H: Stromal score, immune score and ESTIMATE score were higher in the STEAP4 high expression group. STEAP4: Six-transmembrane epithelial antigen of the prostate 4.
- Citation: Fang ZX, Hou YY, Wu Z, Wu BX, Deng Y, Wu HT, Liu J. Immune responses of six-transmembrane epithelial antigen of the prostate 4 functions as a novel biomarker in gastric cancer. World J Clin Oncol 2023; 14(8): 297-310
- URL: https://www.wjgnet.com/2218-4333/full/v14/i8/297.htm
- DOI: https://dx.doi.org/10.5306/wjco.v14.i8.297